Incorporating Software in Combination with Medical Devices Hardware
Published Dec 04, 2023
Published 02nd October 2023
In the domain of Pharmaceutical Regulatory Affairs, regulatory agencies such as EMA and FDA are harnessing the potential of Artifical Intelligence (AI) to revolutionise assessment and oversight. While EMA and FDA are in consultation with stakeholders, we explore AI’s transformative impact and potential challenges ahead. AI enables machines to learn, think, and perform human like tasks, particularly excelling in data analysis and decision making.
Published Dec 04, 2023
Published Nov 21, 2023
Published Nov 02, 2023
Published Oct 26, 2023
Published Oct 24, 2023
Published Oct 12, 2023
Published Sep 29, 2023
Published Sep 25, 2023
Published Sep 20, 2023